Rufinamide
Rufinamide · RUFINAMIDE 100 mg/1 · Tablet, Film Coated · Bushu Pharmaceuticals, Ltd.
NDC 51148-0008-01 · 1 BAG in 1 DRUM / 80000 TABLET, FILM COATED in 1 BAG · DRUG FOR FURTHER PROCESSING · View full market →
Bulk ingredient — not a finished product
This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.
Medicare Part D
This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
90-day shortage risk (model v2)
OAI inspection at a producing facility (24 months) · sole-source market
For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.
Backtested statistical model over the whole market, not this package alone. Model details →
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $1,715.07 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- —
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- —
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Rufinamide (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Aurobindo Pharma Limited | RUFINAMIDE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Aurobindo Pharma Limited | RUFINAMIDE 400 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bushu Pharmaceuticals, Ltd. | RUFINAMIDE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bushu Pharmaceuticals, Ltd. | RUFINAMIDE 100 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Bushu Pharmaceuticals, Ltd. | RUFINAMIDE 400 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | RUFINAMIDE 400 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Camber Pharmaceuticals, Inc. | RUFINAMIDE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Eisai Inc. | RUFINAMIDE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Eisai Inc. | RUFINAMIDE 400 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc., USA | RUFINAMIDE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Glenmark Pharmaceuticals Inc., USA | RUFINAMIDE 400 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | RUFINAMIDE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Hikma Pharmaceuticals USA Inc. | RUFINAMIDE 400 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Lupin Pharmaceuticals, Inc. | RUFINAMIDE 400 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Lupin Pharmaceuticals, Inc. | RUFINAMIDE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Pharma Packaging Solutions, LLC dba Tjoapack LLC | RUFINAMIDE 400 mg/1 | Jul 15, 2026 | Jul 22, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Rufinamide — NDC 51148-0008-01," retrieved September 3, 2026, https://drugdashboards.com/drug/51148000801.
Free to cite with attribution — see how the data is put together.